Showing results (641-650 of 1,751) with videos related to

Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoringDaniel E Speiser, Mikaël J Pittet, Philippe Guillaume, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2004
Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseasesGwen M Wilkie, Clare Taylor, Marie M Jones, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 17, 2021
Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic LeukemiaJu Bai, Jianli Wang, Yun Yang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 10, 2019
Identification of a Promiscuous Epitope Peptide Derived From HSP70Hiroto Matsui, Shoichi Hazama, Koji Tamada, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2014
Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigenHisashi Wada, Midori Isobe, Kazuhiro Kakimi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanomaBruce G Redman, Alfred E Chang, Joel Whitfield, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancerNicolas Acquavella, Harriet Kluger, John Rhee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
Antitumor efficacy of trastuzumab in nude mice orthotopically xenografted with human pancreatic tumor cells expressing low levels of HER-2/neuGraziella Pratesi, Giovanna Petrangolini, Monica Tortoreto, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donorsPatrizia Comoli, Marco W Schilham, Sabrina Basso, et al.
Pageof 176